Companion Animal Pharmaceuticals Market by Product (Analgesics, Anti-infectives, Anti-inflammatory), Indication (Behavioral Disorders, Dermatologic Diseases, Infectious Diseases), Animal Type, Distribution Channel - Global Forecast 2024-2030

Companion Animal Pharmaceuticals Market by Product (Analgesics, Anti-infectives, Anti-inflammatory), Indication (Behavioral Disorders, Dermatologic Diseases, Infectious Diseases), Animal Type, Distribution Channel - Global Forecast 2024-2030


The Companion Animal Pharmaceuticals Market size was estimated at USD 14.73 billion in 2023 and expected to reach USD 16.15 billion in 2024, at a CAGR 9.71% to reach USD 28.21 billion by 2030.

Companion animal pharmaceuticals encompasses the branch of veterinary medicine that is involved in the discovery, development, production, and marketing of drugs for pets, such as dogs, cats, and horses. These pharmaceuticals are designed to treat or prevent a wide range of conditions, from chronic diseases such as diabetes to acute infections or infestations, enhancing the health and well-being of companion animals. As companion animals become more integral to families, there is a rise in the demand for their healthcare. The prevalence of diseases transferable between animals and humans prompts more vigilant healthcare practices for companion animals. However, navigating through rigorous approval processes for new drugs can be time-consuming and costly, impeding the process of drug and pharmaceutical development. Research into cost-effective generic alternatives to branded medication can open up new market segments. Veterinary pharmaceutical companies are expanding into tailored treatment plans based on individual animal genetics, and biometrics can differentiate offerings. Moreover, there have been significant investments in the development of new vaccines and biologic treatments for various diseases.

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Zoonotic and Chronic Diseases
5.1.1.2. Rising Number of Companion Animals and Awareness About their Hygiene
5.1.1.3. Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
5.1.2. Restraints
5.1.2.1. Several Risk Factors Associated with Companion Animal Health APIs
5.1.3. Opportunities
5.1.3.1. Development of New Drugs and Vaccines for Companion Animal
5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
5.1.4. Challenges
5.1.4.1. Stringent Regulations Associated with the Approval for Drugs
5.2. Market Segmentation Analysis
5.2.1. Product: Diverse range of analgesics to treat general and chronic pain in companion animals
5.2.2. Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals
5.2.3. Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments
5.2.4. Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Companion Animal Pharmaceuticals Market, by Product
6.1. Introduction
6.2. Analgesics
6.3. Anti-infectives
6.4. Anti-inflammatory
6.5. Medicated Feed Additives
6.6. Parasiticides
6.7. Vaccines
7. Companion Animal Pharmaceuticals Market, by Indication
7.1. Introduction
7.2. Behavioral Disorders
7.3. Dermatologic Diseases
7.4. Infectious Diseases
7.5. Orthopedic Diseases
7.6. Pain
8. Companion Animal Pharmaceuticals Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
8.4. Horses
9. Companion Animal Pharmaceuticals Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies
9.4. Veterinary Clinics
9.5. Veterinary Hospitals
10. Americas Companion Animal Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Companion Animal Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Zoetis Officially Launches 2 FDA Approved Drugs in the US Veterinary Market
13.3.2. Therapeutics Developer Turns Its Focus To Companion Animal Health
13.3.3. Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
FIGURE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COMPANION ANIMAL PHARMACEUTICALS MARKET DYNAMICS
FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings